Keyphrases
Anticancer Effect
100%
Trastuzumab
100%
Atorvastatin
100%
Hair Loss
100%
Chemobrain
100%
Gray Matter Volume
30%
Trastuzumab Therapy
30%
Tumor
20%
Glucose Metabolism
20%
Therapeutic Efficacy
20%
Gastric Cancer
10%
Quantitative PCR
10%
Frontal Lobe
10%
Cognitive Impairment
10%
Magnetic Resonance Imaging Data
10%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
10%
Human Epidermal Growth Factor Receptor 2 (HER2)
10%
Voxel-based Morphometry
10%
Passive Avoidance Test
10%
Mapping Analysis
10%
Cancer Model
10%
Cerebral Glucose Metabolism
10%
Statistical Parametric Mapping
10%
Enhanced Therapeutic Effects
10%
Rescue Effect
10%
Atorvastatin Treatment
10%
Pharmacology, Toxicology and Pharmaceutical Science
Side Effect
100%
Trastuzumab
100%
Atorvastatin
100%
Hair Loss
100%
Neoplasm
16%
Combination Therapy
16%
Malignant Neoplasm
8%
Cancer Model
8%
Therapeutic Effect
8%
Cognitive Defect
8%
Gamma Urogastrone
8%
Epidermal Growth Factor Receptor 2
8%
Fluorodeoxyglucose
8%
Abdominal Cancer
8%
Medicine and Dentistry
Side Effect
100%
Atorvastatin
100%
Trastuzumab
100%
Glucose Metabolism
25%
Gray Matter
25%
Neoplasm
16%
Combination Therapy
16%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Magnetic Resonance Imaging
8%
Malignant Neoplasm
8%
Cancer Model
8%
Therapy Effect
8%
Positron Emission Tomography
8%
Fluorodeoxyglucose
8%
Cognitive Defect
8%
Epidermal Growth Factor Receptor 2
8%
Gamma Urogastrone
8%
Voxel-Based Morphometry
8%
Frontal Lobe
8%
Passive Avoidance
8%
Abdominal Cancer
8%
Biochemistry, Genetics and Molecular Biology
Anticancer
100%
Atorvastatin
100%
Trastuzumab
100%
Glucose Metabolism
25%
Epidermal Growth Factor Receptor
8%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Magnetism
8%
Animal Model
8%
Positron Emission Tomography
8%
Imaging Software
8%
Passive Avoidance Test
8%
Neuroscience
Atorvastatin
100%
Trastuzumab
100%
Gray Matter
25%
Metabolic Pathway
25%
Magnetic Resonance Imaging
8%
Frontal Lobe
8%
Cognitive Disorders
8%
Positron Emission Tomography
8%
Voxel-Based Morphometry
8%
Statistical Parametric Mapping
8%
Gamma Urogastrone
8%
Epidermal Growth Factor Receptor 2
8%
Reverse Transcription Polymerase Chain Reaction
8%
Immunology and Microbiology
Trastuzumab
100%
Glucose Metabolism
25%
Gray Matter
25%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Magnetic Resonance Imaging
8%
Gamma Urogastrone
8%
Positron Emission Tomography
8%
Imaging Software
8%
Frontal Cortex
8%
Passive Avoidance Test
8%